ALICIA SADER: Open Payments
NPI 1942757562 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,611 in 108 payments from 19 companies in 2025. Trend: 2023 $1,120 · 2024 $1,938 · 2025 $2,611
Food & beverage: $2,591Education: $19
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 14 | $336 |
| Janssen Pharmaceuticals, Inc | 5 | $274 |
| Collegium Pharmaceutical, Inc. | 10 | $208 |
| Supernus Pharmaceuticals, Inc. | 14 | $198 |
| Otsuka America Pharmaceutical, Inc. | 3 | $193 |
| Corium, LLC | 9 | $190 |
| Vanda Pharmaceuticals Inc. | 9 | $183 |
| Lundbeck LLC | 7 | $164 |
| Tris Pharma Inc | 9 | $164 |
| ABBVIE INC. | 5 | $111 |
Products named: REXULTI, SPRAVATO, Auvelity, Jornay PM, Qelbree, Azstarys, Dyanavel XR, HETLIOZ.
Industry payments across KS — which companies pay providers there.
